Literature DB >> 9846952

Meiosis-activating sterols: background, discovery, and possible use.

A G Byskov1, M Baltsen, C Y Andersen.   

Abstract

Several years ago we discovered that spent media from cultured human and bull testes contain components that initiate meiosis in germ cells from fetal mouse testes which have been cultured for 6 days in the spent medium. The active substance(s) was termed meiosis-inducing substance. We later found that human follicular fluid harvested after stimulation with gonadotropins has a similar effect. These meiosis-activating substances have now been identified and characterized in extracts from bull testes and human preovulatory follicular fluid as naturally occurring sterols (meiosis-activating sterols, MAS). MAS are intermediates in the cholesterol biosynthetic pathway and are thus present in all cells which produce cholesterol de novo and from lanosterol. However, MAS accumulate only in the gonads. We discuss the possible physiological role of these sterols in initiating meiosis and in oocyte resumption of meiosis, and their potential use in promoting and preventing fertility.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846952     DOI: 10.1007/s001090050286

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  7 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

2.  Twin enzymes, divergent control: The cholesterogenic enzymes DHCR14 and LBR are differentially regulated transcriptionally and post-translationally.

Authors:  Isabelle M Capell-Hattam; Laura J Sharpe; Lydia Qian; Gene Hart-Smith; Anika V Prabhu; Andrew J Brown
Journal:  J Biol Chem       Date:  2020-01-07       Impact factor: 5.157

3.  The cholesterol-regulated StarD4 gene encodes a StAR-related lipid transfer protein with two closely related homologues, StarD5 and StarD6.

Authors:  Raymond E Soccio; Rachel M Adams; Michael J Romanowski; Ephraim Sehayek; Stephen K Burley; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

Review 4.  Building pathways for ovary organogenesis in the mouse embryo.

Authors:  Chia-Feng Liu; Chang Liu; Humphrey H-C Yao
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

5.  Reducing CYP51 inhibits follicle-stimulating hormone induced resumption of mouse oocyte meiosis in vitro.

Authors:  Chao Wang; Baoshan Xu; Bo Zhou; Cheng Zhang; Jie Yang; Hong Ouyang; Gang Ning; Meijia Zhang; Jianzhong Shen; Guoliang Xia
Journal:  J Lipid Res       Date:  2009-05-11       Impact factor: 5.922

6.  4-Methylzymosterone and Other Intermediates of Sterol Biosynthesis from Yeast Mutants Engineered in the ERG27 Gene Encoding 3-Ketosteroid Reductase.

Authors:  Terenzio Ferrante; Alessandro Barge; Silvia Taramino; Simonetta Oliaro-Bosso; Gianni Balliano
Journal:  Lipids       Date:  2016-07-15       Impact factor: 1.880

Review 7.  Ligands of Therapeutic Utility for the Liver X Receptors.

Authors:  Rajesh Komati; Dominick Spadoni; Shilong Zheng; Jayalakshmi Sridhar; Kevin E Riley; Guangdi Wang
Journal:  Molecules       Date:  2017-01-05       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.